Benzinga''s Top Ratings Upgrades, Downgrades For May 6, 2022 Upgrades For Coupang Inc (NYSE: CPNG ), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading period, Coupang closed at $11.99. According to Guggenheim, the prior rating for NextGen Healthcare Inc (NASDAQ: NXGN ) was changed from Neutral to Buy. In the third quarter, NextGen Healthcare showed an EPS of $0.24, compared to $0.26 from the year-ago quarter. The stock has a 52-week-high of $21.87 and a 52-week-low of $13.64. At the end of the last trading period, NextGen Healthcare closed at $19.52. According to CLSA, the prior rating for Melco Resorts and Entertainment Ltd (NASDAQ: MLCO ) was changed from Outperform to Buy. For the first quarter, Melco Resorts and Enter had an EPS of $0.37, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $19.18 and a 52-week-low of $5.12. At the end of the last trading period, Melco Resorts and Enter closed at $5.19. Raymond James upgraded the previous rating for Jounce Therapeutics Inc (NASDAQ: JNCE ) from Outperform to Strong Buy.